Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 105 | 84 | 54 | 92 | 112 |
| Inventories | 40 | 40 | 40 | 4 | 4 |
| Other current assets | 0 | 0 | 0 | 16 | 0 |
| TOTAL | $147 | $127 | $97 | $112 | $116 |
| Non-Current Assets | |||||
| PPE Net | 1 | 1 | 1 | 1 | 1 |
| Investments And Advances | 12 | 12 | 12 | 12 | 14 |
| TOTAL | $13 | $13 | $13 | $13 | $15 |
| Total Assets | $159 | $140 | $110 | $125 | $131 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 171 | 160 | 129 | 185 | 131 |
| Accounts payable and accrued liabilities | 490 | 490 | 490 | 478 | 475 |
| Accrued Expenses | 226 | 233 | 236 | 232 | 227 |
| TOTAL | $887 | $983 | $955 | $996 | $832 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 69 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $69 |
| Total Liabilities | $887 | $983 | $955 | $996 | $901 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 128,804 | 106,503 | 91,848 | 85,089 | 63,004 |
| Common Shares | 109 | 100 | 85 | 69 | 61 |
| Retained earnings | -6,518 | -6,517 | -6,327 | -5,999 | -5,778 |
| Other shareholders' equity | 1 | 1 | 1 | 1 | 3 |
| TOTAL | $-728 | $-843 | $-845 | $-871 | $-769 |
| Total Liabilities And Equity | $159 | $140 | $110 | $125 | $131 |